Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in ChinaYing Chi, Lunbiao Cui, Yiyue Ge et al.|The Journal of Infectious Diseases|2020Cited by 391
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Yiyue Ge, Jianyang Zeng, Tingzhong Tian et al.|Signal Transduction and Targeted Therapy|2021Cited by 204
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJingxin Li, Tao Zhu, Xiaoqin Chen et al.|The Lancet Respiratory Medicine|2022Cited by 172
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Yiyue Ge, Jianyang Zeng, Tingzhong Tian et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 168
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trialJingxin Li, Fengcai Zhu, Lihua Hou et al.|Nature Medicine|2022Cited by 163